浏览全部资源
扫码关注微信
中国中医科学院 广安门医院,北京 100053
熊兴江,博士,副主任医师,从事经方治疗急危重症研究,Tel:010-88001566,E-mail:xiongxingjiangtcm@163.com
收稿日期:2023-02-13,
网络出版日期:2023-06-06,
纸质出版日期:2023-10-20
移动端阅览
熊兴江.经方治疗急危重症内涵、关键科学问题及体系构建[J].中国实验方剂学杂志,2023,29(20):169-174.
XIONG Xingjiang.Connotation, Key Scientific Issues, and System Building of Classical Herbal Formulae for Critical Care Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):169-174.
熊兴江.经方治疗急危重症内涵、关键科学问题及体系构建[J].中国实验方剂学杂志,2023,29(20):169-174. DOI: 10.13422/j.cnki.syfjx.20232296.
XIONG Xingjiang.Connotation, Key Scientific Issues, and System Building of Classical Herbal Formulae for Critical Care Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):169-174. DOI: 10.13422/j.cnki.syfjx.20232296.
中医学在现今临床上高度重视慢性疑难病、“未病”的治疗,而对急危重症的治疗提及不多,甚至在急诊、急救领域大有阵地不断萎缩趋势。急危重症是指在临床上具有病情急、病势重、进展快、死亡率高的一类疾病。历代中医名家的成长心路历程,无一不是在处理急危重症的实践经历中磨练砥砺而成。《伤寒论》是一部治疗急危重症的专著,而经方尤为《伤寒论》中治疗急危重症的核心与精华。在临床现状方面,突破现行普遍认为的只有门诊上的慢性疾病、调理类疾病才是中医学的“优势病种”的思维定势,寻找中医在急危重症领域的临床优势切入点,探索《伤寒论》与重症医学的学科交叉,提升经方治疗急危重症能力,建立经方治疗急危重症的学科体系,揭示经方治疗急危重症的临床证据,提升中医学在急危重症领域的贡献度,已成为现今中医临床的强烈呼唤与需求。在关键科学问题方面,经方治疗急危重症的体系涵盖伤寒本质、六经实质、条文内涵与经方剂量等传统核心理论。在未来的学术传承与体系构建上,以临床难题为导向,突破现行传统经典学科体系存在的模式单一,创新能力薄弱,转化能力不足等问题,建议明确急危重症领域的中医优势病种,倡导基于“病机结合病理,药性结合药理”的研究模式,树立多学科的综合思维模式,鼓励倡导医教研产协同创新研究,为完善经方治疗急危重症体系构建的路径与关键。
In contemporary clinical practice of traditional Chinese medicine (TCM), there is a strong emphasis on treating chronic difficult diseases and preventing diseases before they occur ("pre-disease" treatment). However, the treatment of critical care medicine has not received as much attention and is even facing a trend of diminishing influence in the field of emergency medicine and critical care. Critical care medicine refers to a class of diseases that are characterized by rapid onset, severity, quick progression, and high mortality rates in clinical practice. The growth and development of renowned TCM experts throughout history have invariably been honed through practical experiences in managing critical care medicine.
Treatise on Cold Damage
(《伤寒论》) is a dedicated work for treating critical care medicine, and the classic prescriptions in
Treatise on Cold Damage
are particularly central to the treatment of these diseases. In the current clinical context, it is important to break through the prevailing mindset that the strengths of TCM lie solely in treating chronic diseases and maintenance-type illnesses, identify the entry point of TCM in the clinical advantages in the field of critical care medicine, explore the interdisciplinary relationship between
Treatise on Cold Damage
and critical care medicine, enhance the ability to treat critical care medicine using classic prescriptions, establish a disciplinary system for prescription-based treatment of critical care medicine, reveal clinical evidence for prescription-based treatment of these diseases, and elevate the contribution of TCM in the domain of critical care medicine. These have become a strong call and demand in contemporary TCM clinical practice. Regarding key scientific issues, the system of using classic prescriptions to treat critical care medicine encompasses traditional core theories such as the nature of cold damage, the essence of the six meridians, the implications of specific clauses, and the dosages of classic prescriptions. In the context of future academic inheritance and system construction, it is recommended to focus on clinical challenges, break away from the current limitations of traditional classical disciplinary systems, such as their singular patterns and weak innovative and translational capabilities, suggest defining diseases in critical care medicine responding specifically to TCM, advocate a research model based on combining disease mechanisms with pathology and combining medicinal properties with pharmacology, establish a comprehensive multidisciplinary thinking mode, and encourage collaborative innovative research among medical, educational, research, and manufacturing institutions. This will help chart the path and address key aspects of constructing a comprehensive system for prescription-based treatment of critical care medicine.
熊兴江 . 《伤寒论》与急危重症——基于CCU重症病例及中西医结合诠释经典条文内涵、经方剂量与六经实质 [J]. 中国中药杂志 , 2018 , 43 ( 12 ): 2413 - 2430 .
熊兴江 . 木防己汤方证特征及其治疗重症心衰研究 [J]. 中国中药杂志 , 2019 , 44 ( 2 ): 388 - 400 .
熊兴江 , 尤虎 , 苏克雷 . 中药补益膏方对重症心衰“虚劳”的二级预防 [J]. 中国中药杂志 , 2019 , 44 ( 18 ): 3903 - 3907 .
谢胜 , 刘园园 , 张丽敏 , 等 . 从“五痹”切入探讨危急重症的中西医病机融通与组方思路 [J]. 广西科学 , 2022 , 29 ( 6 ): 1021 - 1025 .
黄煌 . 经方医学的源流与现状分析 [J]. 上海中医药杂志 , 2009 , 43 ( 1 ): 6 - 9 .
陈腾飞 , 刘清泉 . 中医药与急诊重症医学 [J]. 中华中医药杂志 , 2016 , 31 ( 9 ): 3412 - 3416 .
郑玉娇 , 赵林华 , 李青伟 , 等 . 从《伤寒论》形成渊源探究伤寒其貌 [J]. 辽宁中医杂志 , 2020 , 47 ( 10 ): 69 - 71 .
姬航宇 , 仝小林 , 赵林华 , 等 . 《伤寒论》与《汤液经法》药物剂量溯源考 [J]. 上海中医药大学学报 , 2011 , 25 ( 3 ): 23 - 25 .
仝小林 , 穆兰澄 , 姬航宇 , 等 . 《伤寒论》药物剂量考 [J]. 中医杂志 , 2009 , 50 ( 4 ): 368 - 372 .
韩佳瑞 , 于淼 , 余秋平 , 等 . 中药临床合理剂量科学方法体系的构建 [J]. 中医杂志 , 2011 , 52 ( 20 ): 1739 - 1740 .
熊兴江 . 基于CCU重症病例的《伤寒六书》柴葛解肌汤方证及其在医院内感染、急性上呼吸道感染等外感热病中的运用 [J]. 中国中药杂志 , 2019 , 44 ( 18 ): 3876 - 3882 .
熊兴江 . 基于临床重症病例的麻黄附子细辛汤方证特征及其治疗脓毒症、多脏器功能衰竭、气管插管术后高热不退、急性心梗合并糖尿病末梢神经病变剧烈疼痛研究 [J]. 中国中药杂志 , 2019 , 44 ( 18 ): 3869 - 3875 .
熊兴江 . 基于临床重症病例及中西医结合解读《伤寒论》白虎加人参汤方证及其退热、升压、纠正高渗、降糖的治疗急危重症体会 [J]. 中国中药杂志 , 2019 , 44 ( 18 ): 3861 - 3868 .
熊兴江 . 基于现代病理生理及CCU急危重症病例的炙甘草汤方证溯源及其复律、转窦、止血、升血小板、补虚临床运用 [J]. 中国中药杂志 , 2019 , 44 ( 18 ): 3842 - 3860 .
熊兴江 . 《金匮要略》“中风篇”防己地黄汤、风引汤方证及其在中风、神志疾病中的运用 [J]. 中国中药杂志 , 2019 , 44 ( 3 ): 602 - 607 .
熊兴江 . 古代“中风”内涵及《千金要方》小续命汤治疗脑梗死、脑出血体会 [J]. 中国中药杂志 , 2020 , 45 ( 12 ): 2725 - 2734 .
仝小林 , 盛梅笑 , 杨金荣 . 瘟疫危重证2例治验 [J]. 实用中医内科杂志 , 1988 , 2 ( 4 ): 189 - 190 .
仝小林 , 崔新育 . 伤寒方治疗急证3则 [J]. 实用中医内科杂志 , 1997 , 11 ( 4 ): 7 - 8 .
熊兴江 . 《伤寒论》研究亟需中西医结合 [J]. 中国中西医结合杂志 , 2021 , 41 ( 7 ): 865 - 867 .
陈腾飞 , 刘清泉 . 中医重症医学教学之探讨 [J]. 中国中医急症 , 2021 , 30 ( 9 ): 1664 - 1667 .
姚魁武 . 转化医学为中西医结合的发展架起了有益桥梁 [J]. 转化医学电子杂志 , 2018 , 5 ( 3 ): 1 - 2 .
姚魁武 . 深化师承教育促中医药学纵深发展 [J]. 中国卫生人才 , 2018 , 23 ( 8 ): 26 - 28 .
黄煌 . 经方方证的四大特征 [J]. 南京中医药大学学报 , 2022 , 38 ( 8 ): 651 - 654 .
0
浏览量
34
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构